BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28952836)

  • 1. A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis.
    Bao L; Mohan GC; Alexander JB; Doo C; Shen K; Bao J; Chan LS
    Innate Immun; 2017 Nov; 23(8):641-647. PubMed ID: 28952836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.
    Bao L; Alexander JB; Zhang H; Shen K; Chan LS
    J Interferon Cytokine Res; 2016 Jun; 36(6):374-81. PubMed ID: 26918372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
    Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
    Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
    Bao L; Shi VY; Chan LS
    Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
    Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
    Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
    Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
    Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
    Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.
    Kim BE; Leung DY; Boguniewicz M; Howell MD
    Clin Immunol; 2008 Mar; 126(3):332-7. PubMed ID: 18166499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
    Furue M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
    Kamsteeg M; Bergers M; de Boer R; Zeeuwen PL; Hato SV; Schalkwijk J; Tjabringa GS
    Am J Pathol; 2011 May; 178(5):2091-9. PubMed ID: 21514424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes.
    Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW
    J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip.
    Kim K; Kim H; Sung GY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid abnormalities in atopic skin are driven by type 2 cytokines.
    Berdyshev E; Goleva E; Bronova I; Dyjack N; Rios C; Jung J; Taylor P; Jeong M; Hall CF; Richers BN; Norquest KA; Zheng T; Seibold MA; Leung DY
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Polymorphism of Interleukin-4, Interleukin-4 Receptor and STAT6 in Children with Atopic Dermatitis in Taif, Saudi Arabia.
    Hussein YM; Alzahrani SS; Alharthi AA; Alhazmi AS; Ghonaim MM; Alghamdy AA; El Askary A
    Immunol Invest; 2016; 45(3):223-34. PubMed ID: 27018548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
    Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
    BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis.
    Hatano Y; Adachi Y; Elias PM; Crumrine D; Sakai T; Kurahashi R; Katagiri K; Fujiwara S
    Exp Dermatol; 2013 Jan; 22(1):30-5. PubMed ID: 23173934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yin-yang 1 negatively regulates the differentiation-specific transcription of mouse loricrin gene in undifferentiated keratinocytes.
    Xu X; Kawachi Y; Nakamura Y; Sakurai H; Hirota A; Banno T; Takahashi T; Roop DR; Otsuka F
    J Invest Dermatol; 2004 Dec; 123(6):1120-6. PubMed ID: 15610523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
    Zeng YP; Nguyen GH; Jin HZ
    Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.